Naphthylvinylpyridine
Appearance
![]() | |
Names | |
---|---|
Preferred IUPAC name
4-[(E)-2-(Naphthalen-1-yl)ethen-1-yl]pyridine | |
Identifiers | |
| |
3D model (JSmol)
|
|
ChemSpider | |
ECHA InfoCard | 100.203.347 |
MeSH | D009286 |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
C17H13N | |
Molar mass | 231.29 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Naphthylvinylpyridine (NVP) is a naphthalene derivative that possesses anticholinergic activity similar to that of atropine. However, NVP's method of acetylcholine (ACh) antagonism involves inhibiting the enzyme choline acetyltransferase.[1]
Several NVP derivatives have been synthesized and evaluated for their ability to inhibit choline acetyltransferase and protect against nerve toxins.[2][3]
References
- ^ Haubrich, DR; Goldberg, ME (1975). "Homovanillic acid concentration in the rat brain: Effect of a choline acetyltransferase inhibitor and comparison with cholinergic and dopaminergic agents". Neuropharmacology. 14 (3). Squibb Institute for Medical Research: 211–214. doi:10.1016/0028-3908(75)90007-6. PMID 1134625. S2CID 28216329.
- ^ Cozzari, Costantino; Hartman, BK (1983). "Synthesis of a naphthylvinylpyridine derivative and its use for affinity chromatography of choline acetyltransferase". Analytical Biochemistry. 133 (1). Department of Psychiatry and Neurobiology, Washington University School of Medicine: 120–125. doi:10.1016/0003-2697(83)90231-2. PMID 6638474.
- ^ Gray, AP; Henderson, TR (1988). "Approaches to protection against nerve agent poisoning". J Med Chem. 31 (4). Dynamac Corporation: 807–814. doi:10.1021/jm00399a022. PMID 3351860.